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Abstract
Background
Group 2 Innate lymphoid cells (ILC2s) are innate cells that produce the TH2 cytokines IL-5
and IL-13. The importance of these cells has recently been demonstrated in experimental
models of parasitic diseases but there is a paucity of data on ILC2s in the context of human
parasitic infections and in particular of the blood dwelling parasite Schistosoma
haematobium.
Methodology/Principal Findings
In this case-control study human peripheral blood ILC2s were analysed in relation to infec-
tion with the helminth parasite Schistosoma haematobium. Peripheral blood mononuclear
cells of 36 S. haematobium infected and 36 age and sex matched uninfected children were
analysed for frequencies of ILC2s identified as Lin-CD45+CD127+CD294+CD161+. ILC2s
were significantly lower particularly in infected children aged 6–9 years compared to healthy
participants. Curative anti-helminthic treatment resulted in an increase in levels of the acti-
vating factor TSLP and restoration of ILC2 levels.
Conclusion
This study demonstrates that ILC2s are diminished in young helminth infected children and
restored by removal of the parasites by treatment, indicating a previously undescribed
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association between a human parasitic infection and ILC2s and suggesting a role of ILC2s
before the establishment of protective acquired immunity in human schistosomiasis.
Author Summary
Understanding how immune responses are generated is critical for vaccine development.
There are comparatively few studies on the interface between the innate and adaptive im-
mune system in generating protective immune responses. Infections with helminth para-
sites, a cause of neglected tropical diseases, have a huge collective impact on public health
in affected developing countries. Helminths are associated with a complex type 2 immune
response mediated by cytokines characteristically produced by adaptive T helper 2 cells
(TH2). However in recent years a newly described type of innate immune cells has been
shown to produce TH2 cytokines. This cell type was subsequently called ‘Group 2 innate
lymphoid cells’ (ILC2s). The importance of these cells has been demonstrated in experi-
mental models of helminth infection as well as in allergic diseases. The present study de-
scribes changes in human ILC2s during the human helminth infection schistosomiasisas
(bilharzia). Our study shows that the proportions of ILC2s, were lower in young, but not
older infected children when compared to uninfected participants, suggesting a role for
ILC2s before the establishment of helminth protective acquired immunity. Furthermore
ILC2s were restored after curative treatment of the helminth infection. Human mechanis-
tic studies will determine if the association between ILC2s and schistosome infection is
causal or a marker of resistance to infection.
Introduction
Innate lymphoid cells are a recently described cell type that has transformed our understanding
of the role of innate immune responses in the generation of adaptive immune responses.
Group 2 Innate lymphoid cells (ILC2s) produce the classical TH2 cytokines IL-5 and IL-13
[1–3] and have been shown to be crucial for protective immune responses in experimental hel-
minth infection [4–6]. ILC2s play an important role as an early source of IL-13 and are crucial
for timely worm expulsion in mice infected with the murine helminth parasite Nippostrongylus
brasiliensis. However, to date there is only one study in humans which characterised ILCs in a
small population of patients with diverse filarial infections [7].
The interaction of helminth parasites and the host immune system has been extensively
studied in experimental models and naturally infected humans. In experimental models, the
immune responses to helminths, including schistosome infections, is polarized towards a type
2 immune response (reviewed in [8–10]). However, research over the last decade has shown
that the establishment of helminth infections requires modulation of host type 2 responses,
which is mediated by several different mechanisms including regulatory T cells, regulatory B
cells and the immuno-modulatory cytokines IL-10 and TGF-β [11–15]. To a large extent these
observations have been supported by evidence from human studies [16–18]. Type 2 immune
responses have been shown to involve innate immune cells including dendritic cells, basophils
and alternatively activated macrophages [19–21]. However in human, TH2 responses to hel-
minth infections are less pronounced [22, 23]. In addition, humans infected with helminths
show alterations of cellular responses such as regulatory T cells, dendritic cells and CD4+ T
Cell responses [16, 24, 25] and these responses vary with age (and thereby with history of
ILC2s in Human Parasitic Infection
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infection with helminths). Thus, the specific characteristics of the human type 2 response to
helminths are more complex than in experimental models meaning that observations from the
experimental setting must be validated in natural human infections.
Human ILC2s are negative for lineage markers (Lin-), but positive for the hematopoietic
cell marker CD45 [26]. IL-7 is essential for the development of ILC2s [5, 27] and therefore
CD127 (IL-7Rα) is a main marker for characterising ILC2s. Furthermore human ILC2s express
the ‘chemokine receptor homologous molecule expressed on TH2 cells’ (CRTH2 = CD294) a
marker of TH2 cells [28] and expressed the NK cell receptor CD161 (NKR-P1A) [26], whereas
CD117 (c-kit) is mainly expressed on ILC3 and only on a subset of ILC2s [2].
ILC2s were initially described in fetal and adult gut and lung, but have also been identified
in peripheral blood [26], but the function of blood ILC2s has not yet been investigated in detail.
Changes in proportions of blood ILC2s could reflect either a global modulation of ILC2s or
changes in the potential to migrate to tissues.
ILC2s are dependent on the TH2-associated transcription factors GATA-3 [29, 30] and
RORα [27, 31] and the ‘thymic stromal lymphopoietin’ TSLP enhances GATA-3 expression
and subsequent production of IL-4, IL-5 and IL-13, especially if supplied in combination with
IL-33, but less efficiently with IL-25 [32]. Changes of systemic IL-33 during helminth infection
have been recently reported [33].
The presence of ILC2s in human peripheral blood has been demonstrated in healthy indi-
viduals and in patients with mild or severe asthma [34, 35]. Furthermore, in mouse models
ILC2s as well as IL-25 and IL-33, have been shown to be involved in allergic immune responses
[36–41].
The aim of this study was to determine if levels of blood ILC2s change in the context of a
parasitic infection in a human population, thereby providing evidence that ILC2s are impor-
tant in human parasitic diseases. The study focused on the helminth parasite of the genus Schis-
tosoma (blood-flukes) which causes schistosomiasis, a neglected tropical disease affecting
about 240 million people mainly in Sub-Saharan Africa [42]. The most prevalent form is uro-
genital schistosomiasis caused by Schistosoma haematobium. The heaviest burden of this
helminthic disease occurs in children, who typically acquire infection in the first year of life
[43, 44]. Infection accumulates with age, and in most populations peaks around the age of 9–14
years, followed by a decrease in infection [45, 46] which has been attributed to the development
of protective acquired immunity [47, 48]. Therefore immune epidemiological analyses covering
these different stages of infection have been shown to be important in the analysis of the im-
mune response towards helminth infections [16, 24, 25].
In this study we describe for the first time, alterations of ILC2 proportions in human blood
during natural infection with schistosomes in a heterogeneous population (different ages to
capture the different infection dynamics of rising, peaking and declining infection levels) and
the effect of removing the helminth parasites through curative anti-helminthic drug treatment
on ILC2 proportions. To elucidate pathways involved in changes of ILC2s, levels of the ILC2
activating factors TSLP and IL-33 were analysed.
Methods
Ethical statement
The study received institutional and ethical approval from the Ethical Review Board of the Uni-
versity of Zimbabwe and the Medical Research Council of Zimbabwe respectively. Permission
to conduct the study in the selected area was obtained from the Provincial Medical Director,
the District Educational Officer and School Heads. The aims and procedures of the study were
explained to participants and their parents/guardians (in the case of children) in the local
ILC2s in Human Parasitic Infection
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language, Shona, with written informed consent and assent obtained from the participants or
parents/guardian before enrolment into the study and before administration of the anti-hel-
minthic drug. Participants were free to drop out at any time of the study and parents/guardian
could withdraw their children from the study. After sample collection, anti-helminthic treat-
ment with the standard dose of praziquantel was offered to all participants and administered
by a local physician.
Study area and design
This study was conducted in Magaya village in the Murehwa district of the Mashonaland East
Province of Zimbabwe (31°91’E; 17°63’S) as part of a larger study investigating the immuno-
epidemiology of human urogenital schistosomiasis of which several aspects have been pub-
lished [24, 25, 49, 50]. Samples used within this study were collected between September and
November 2008. Previous studies in this area and national surveys indicated low prevalence’s
of S.mansoni and soil-transmitted helminths (STH), whereas the S. haematobium prevalence
was high (>50%) [51, 52]. The area is mesoendemic for Plasmodium infection [53].
Magaya is a rural village where subsistence farming is the predominant occupation. Due to
lack of safe water and sanitation facilities, participants are in frequent contact with fresh water,
which harbours the parasite life stage (cercariae) infective to the human host. Frequency of
water contacts of participants, their history of anti-helminthic treatment and residential history
in the schistosome endemic area were documented by questionnaires.
Study group
To be included in the cross-sectional part of the study, participants had to meet the following
criteria: a) been lifelong residents of the study area, b) not have previously received anti-hel-
minthic treatment, c) be negative for S.mansoni, STH, Plasmodium falciparum (ensuring that
the confounding effects of these parasites were excluded from the study) and HIV, d) have pro-
vided at least two urine and two stool samples on consecutive days for parasitological analysis
and a blood sample sufficient for PBMC and plasma isolation. From the participants who ful-
filled these criteria a group of 72 people were selected covering an age range of 6–18 years with
24 people in each of following three age groups: 6–9, 10–13, 14–18 years. Within each age
group equal numbers of uninfected and infected people were selected providing a S. haemato-
bium prevalence of 50%. Furthermore participants were age and sex matched between the un-
infected and infected groups. Egg positive samples were chosen to have comparable infection
intensities between the three age groups. The resulting study group is shown in Table 1.
The effect of removing the parasites on ILC2s and levels of the activating factors TSLP and
IL-33 were determined in a cohort study where participants were treated with the anti-helmin-
thic drug praziquantel at the recommended dose of 40 mg/mL and followed up 6 weeks later
(before re-infections reach patency) as recommended [54]. To be included in this study partici-
pants had to meet the following criteria a) been included in the cross-sectional study described
above, b) been positive for infection with S. haematobium parasites at baseline, c) been treated
with the anti-helminthic drug praziquantel, d) have provided at least two urine and two stool
samples for a parasitology check and have been confirmed negative for infection with S. hae-
matobium parasites 6 weeks after treatment, e) provided a blood sample for isolation of PBMC
and plasma at the 6 week post-treatment survey. Twelve participants, 9 males and 3 females,
with a mean age of 9.58 years (range 6–13 years) and a mean infection intensity of 43.0 eggs/10
mL (range 3.0–158.3) before treatment fulfilled these criteria.
ILC2s in Human Parasitic Infection
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Parasitology, blood collection and isolation of PBMC
At least two urine and two stool samples were collected over three consecutive days (between
9am and 1pm). Infection with S. haematobium was determined by filtration of 10 mL urine
and microscopic analysis following the standard urine filtration procedure [55]. Infection with
S.mansoni and STH was determined in stool samples using the Kato-Katz method [56], with
the results confirmed in a random subset of stool samples by the formol-ether concentration
technique [57].
Up to 20 mL of venous blood was collected into heparinised blood collection tubes and a
further five mL into EDTA coated tubes. Blood was analysed for HIV using the rapid test ‘Dou-
bleCheckGoldTM HIV 1&2’ (Orgenics) and positive samples were re-tested using ‘Determine
HIV ½ Ag/Ab Combo’ (InvernessMedical). Blood smears were stained with Giemsa, micro-
scopically examined for Plasmodium falciparum and checked using a serological test (Para-
check-PF1, Orchid Biomedical Systems). Heparinised blood was used for the isolation of
PBMCs through density gradient centrifugation LymphoprepTM (Axis-Shield). PBMC were
cryopreserved in 10% DMSO (Sigma) and 90% fetal calf serum (Lonza).
Phenotyping ILC2 and plasma analysis
1x106 PBMCs were surface stained using the following anti-human antibodies: FITC-conjugat-
ed lineage cocktail (BD Bioscience) containing CD3, CD14, CD16, CD19, CD20, CD56, FITC-
conjugated anti-CD11c (clone 3.9), FITC-conjugated anti-CD123 (clone 6H6), e450-conjugat-
ed anti-CD161 (HP-3G10), APC-e780-conjugated anti-CD127 (eBioRDR5; all eBioscience),
VioGreen-conjugated anti-CD45 (clone 5B1), APC-conjugated anti-CD117 (A3C6E2), PE-
conjugated anti-CD294 (BM16; all Miltenyi Biotec). At least 4x105 stained PBMCs were ac-
quired on a FACSCantoIITM (BD Bioscience) and analysed using FlowJo7 software (TreeStar).
Previous experiments confirmed that cryopreserved PBMCs did not include any basophils and
mast cells using this phenotyping approach. Plasma levels of TSLP and IL-33 by ELISA were
Table 1. Description of the selected study group.
Age group
(years)
S. haematobium
Status
Sample size
(N)
Mean age
(years)
S. haematobium Infection intensity: Mean / Median
(range)
M/F
6–9 egg ve- 12 7.83 0 6/6
egg ve+ 12 7.92 28.3 / 16.0 (2.7–158.3) 6/6
Total 24 7.88 14.1 / 1.3 (0–158.3) 12/
12
10–13 egg ve- 12 11.58 0 4/8
egg ve+ 12 12.75 34.4 / 23.3 (3.0–132.0) 7/5
Total 24 12.17 17.2 / 1.5 (0–132.0) 11/
13
14–18 egg ve- 12 15.33 0 5/7
egg ve+ 12 14.92 31.6 / 21.5 (1.7–100.3) 5/7
Total 24 15.12 15.8 / 0.8 (0–100.3) 10/
14
Total (6–18) Prevalence 50% 72 11.64 15.2 / 0.8 (0–158.0) 33/
39
All participants were negative for HIV, soil transmitted helminths and S. mansoni; M—male, F—female, infection intensity: eggs / 10 mL urine; ve-
negative, ve+ positive
doi:10.1371/journal.pntd.0003627.t001
ILC2s in Human Parasitic Infection
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analysed using commercially available kits (eBioscience and RnD systems respectively). IL-4,
IL-5 and IL-13 were measured using established protocols [50, 58].
Statistical analysis
Since the data did not meet the assumptions of parametric tests, all statistical analyses were car-
ried out using non-parametric tests. For the comparison of two groups (egg negative versus egg
positive, male versus female), Mann-Whitney U test was applied, for multiple groups the Krus-
kal-Wallis test followed by a post-hoc comparison (Mann-Whitney U test with Bonferroni cor-
rection) was used. For comparison of paired data (pre- versus post-treatment) the Wilcoxon
signed-rank test was applied. Correlations were tested using a Spearman's rho analysis. All sta-
tistical analysis was carried out using IBM SPSS v19 and p-values were taken as significant if
0.05.
Results
Characterisation of human ILC2s
To identify human peripheral blood ILC2s, Mjösberg and co-workers [26] depleted PBMCs
from T cells, B cells and monocytes, followed by a flow cytometric analysis of the remaining
cells. This approach was not practical here, due to a much larger sample size used in the present
study, and as cell numbers were limited. We therefore directly stained whole PBMCs with a
lineage cocktail, which also included the NK cell marker CD56. PBMCs were gated on live cells
and duplicates excluded (Fig. 1A). Gated single cells were analysed by a Lin cocktail and CD45,
Fig 1. Characterisation of human ILC2 by flow cytometry. (A) Human PBMC were gated on live cells
using forward (FSC) and side (SSC) scatter. Gated live cells were analysed using the area against height of
the FSC to discriminate singlet’s from duplicates. Singlet’s were subsequently analysed by a lineage cocktail
(Lin) and CD45 to gate on Lin-CD45+ cells (as indicated in the box) (B). Lin-CD45+ cells were gated on
CD127+ cells, which were analysed for CD294 and CD161 (C). CD127+CD294+CD161+ were analysed for
CD117 (grey histogram) versus isotype control (open histogram) (D). Flow charts as presented are from the
PBMC analysis of a 9 year old female who was negative for S. haematobium eggs.
doi:10.1371/journal.pntd.0003627.g001
ILC2s in Human Parasitic Infection
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which showed a Lin- negative population expressing CD45. Within this population a CD45hi
and a CD45int population, could be clearly distinguished.
To identify human ILC2s, Lin-CD45+ PBMCs were gated on CD127+ (Fig. 1B). Within
Lin-CD45+CD127+ cells a defined population of CD294+CD161+ cells could be identified
(Fig. 1C). CD294+CD161+ cells contained both a CD117+ and a CD117- subset (Fig. 1D). In
reverse CD127+CD117+ ILCs did not exclusively define CD294+ and CD161+ cells (Median
of CD294+CD161+ in CD127+CD117+: 45.6, range 13.1–74.7) and it is known that CD117+
compromise both ILC2s and ILC3s. Of note, CD127+CD294+CD161+ subsets are all CD45hi.
In summary, although not completely homogenous Lin-CD45+CD127+CD294+CD161+ cells
define a population of human blood ILC2s, hence CD127+CD294+CD161+ ILC2s were used
in subsequent analyses.
Proportions of ILC2s are diminished during parasitic helminth infection
Next, the effect of current schistosome status on the proportions of blood ILC2s was analysed.
The analyses showed that CD127+CD294+CD161+ ILC2s were all significantly lower in schis-
tosome-infected individuals (p = 0.027) when levels of these cells were expressed as percentages
of lin-CD45+CD127+ (Fig. 2A). This was also true if ILC2s were expressed as percentages of
lin-CD45+ (Median: 4.8 egg negative (ve-), 3.1 egg positive (ve+) p = 0.044). In addition pro-
portions of ILC2s were negatively correlated to the intensity of infection determined by egg
count (r = −0.300, p = 0.005 using non-parametric Spearman correlation). Of note, CD127+
CD117+ ILCs show a comparable pattern (Median: 13.7 egg ve-, 7.5 egg ve+, p = 0.001).
To determine if these differences were consistent across age groups undergoing different
schistosome infection dynamics, the population was divided into three age groups, 6–9, 10–13
and 14–18 year olds reflecting rising, peaking and declining infection levels. This analysis
showed that ILC2s in infected participants were significantly lower than those in uninfected
people of the youngest age group (Fig. 2B). This difference was not significant in children aged
10–13 years and proportions of ILC2s were comparable in the oldest age group aged 14–18
years. Comparable results were obtained if ILC2s levels were correlated to infection intensity.
Fig 2. Proportions of ILC2s identified by CD127+CD294+CD161+ are lower in S. haematobium egg
positive young children. (A) The participants were compared between S. haematobium egg negative (ve-,
N = 36) and egg positive (ve+, N = 36) individuals by a non-parametric Mann-Whitney U test. (B) The cohort
was divided into three age groups (age in years) and egg positive (ve+, open symbols) were compared to egg
negative (ve-, closed symbols) people. Grey lines indicate median and the interquartile range. ILC2s
proportions were analysed using a Kruskal-Wallis test followed by a multiple comparison of egg positive
versus egg negative children.
doi:10.1371/journal.pntd.0003627.g002
ILC2s in Human Parasitic Infection
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The youngest age group showed a strong negative correlation between infection intensity and
ILC2 proportions (r = −0.483, p = 0.008), whereas a weaker negative correlation was observed
in 10–13 old participants (r = −0.403, p = 0.025) and with no significant correlation in the 14–
18 years old (r = −0.045, p = 0.418).
CD127 (IL-7Rα) was used for identification of ILC2s, allowing the actual expression levels
(MFI) of CD127 on ILC2s to be measured. Expression levels of CD127 did not show significant
variation between infected and uninfected people for all age groups (6–9 years: p = 0.514; 10–
13 years: p = 0.114; 14–18 years: p = 0.551).
Of note, levels of the systemic effector TH2 cytokines IL-4, IL-5 and IL-13 did not show any
association with peripheral ILC2s (i.e. ILC2s to IL-4: r = −0.113 (p = 0.346); to IL-5 r = 0.138
(p = 0.248 and to IL-13 r = 0.016 (p = 0.894) using non-parametric Spearman correlation).
Systemic TH2 cytokines were positively associated to infection intensity only in the oldest age
group (IL-4: r = 0.488, p = 0.008; IL-5: r = 0.400, p = 0.027; IL-13: r = 0.497, p = 0.007). Detailed
data for the TH2 cytokines are presented in S1 Fig with IL-5 and IL-13 only significant in chil-
dren 14–18 years of age.
Curative anti-helminthic treatment restores ILC2 levels
To test if the differences in the ILC2 proportions were related to the presence of schistosome
parasites, schistosome adult worms were removed by curative treatment and analysed in 12
children aged 6–13 years who were S. haematobium positive prior to treatment and had cleared
infection 6 weeks later were followed up and proportions of ILC2s were determined. The over-
all proportions of their ILC2 cells increased significantly post-treatment as shown in Fig. 3A.
Older egg negative participants have putatively developed a protective immune response
and have been referred to in other studies as endemic normal and a high worm specific IgE/
IgG4 ratio is a marker for schistosome-specific resistance [25]. Curative treatment by
Fig 3. Proportions of ILC2s increase 6 weeks after curative anti-helminthic treatment with
praziquantel in children aged 6–13 years. (A) The proportions of ILC2s of 12 individuals who were positive
pre-treatment and had cleared S. haematobium infections 6 weeks post-treatment were analysed using a
non-parametric Wilcoxon signed-rank test. Numbers in the lower-right corner indicate positive/negative
ranks. Grey lines are individuals 10–13 years whereas black lines present children 6–9 years of age. (B) The
proportions of ILC2s compared between the 12 children aged 6–13 years who had completely cleared their S.
haematobium infections 6 weeks post-treatment (open triangles) and the 12 participants aged 14–18 years
who were already S. haematobium negative before treatment (black squares). Grey lines indicate median
and the interquartile range.
doi:10.1371/journal.pntd.0003627.g003
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PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003627 March 23, 2015 8 / 16
chemotherapy has been shown to accelerate the development of a protective immune response
[59], hence post-treatment levels of ILC2 were compared to egg ve- individuals aged 14–18
years. Post-treatment, levels of ILC2 rose up to levels observed in untreated 14–18 year old par-
ticipants who were egg negative prior to treatment (Fig. 3B).
After dividing these 12 children into two groups of 6–9 and 10–13 years of age, ILC2s in-
creased in 5 out of 7 and in 4 out of 5 children, respectively.
The increase of ILC2 levels were inversely related to the pre-treatment levels of these cells,
with the lowest pre-treatment proportions exhibiting the highest magnitude of change post-
treatment. We have previously reported this phenomenon in changes in antibody levels in chil-
dren exposed to S.mansoni infection [59].
Curative anti-helminthic treatment increases TSLP levels
Maintenance and activation of ILC2s has been reported to depend on the cytokines IL-25, IL-
33 and TSLP. Pre-treatment plasma levels of IL-33 and TSLP were measured, but no significant
difference was observed when egg negative and egg positive children were compared regardless
of the age group investigated (Fig. 4A, B). However TSLP levels increased significantly 6 weeks
Fig 4. Comparison of plasma TSLP and IL-33 levels in relation to S. haematobium infection. Plasma
levels of (A) TSLP and (B) IL-33 were measured by ELISA and data were divided into three age group and S.
haematobium egg negative (ve-, closed symbols) compared to egg positive (ve+, open symbols) individuals.
Grey lines indicate median and the interquartile range. Levels were compared using a Kruskal-Wallis test
followed by a multiple comparison of egg positive versus egg negative children. Plasma levels of (C) TSLP
and (D) IL-33 from 12 individuals (as described for Fig. 3) were compared pre- and 6 week’s post-treatment.
P-values are obtained from aWilcoxon signed-rank test and positive/negative/unchanged ranks are shown in
the lower-right corner of panel (C) and (D).
doi:10.1371/journal.pntd.0003627.g004
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after curative treatment (Fig. 4C). In contrast, the level of IL-33 remained unchanged following
treatment (Fig. 4D).
Discussion
In parasitic infections, ILC2s have been described in experimental models of helminth infec-
tions demonstrating their role as an early source of the cytokine IL-13 and in worm expulsion
[4, 6, 60–62]. Given these results, this study aimed to determine if ILC2s populations are al-
tered during human parasite infections using an immuno-epidemiological approach reflecting
the complex dynamics during human parasite infections and specifically focusing on young
children with accumulating infection. Hence, included in the study are young children who
have yet to acquire schistosome infection (negative for schistosome eggs and parasite-specific
antibodies), infected young and older children (schistosome egg positive) and older children
putatively resistant to schistosome infection (schistosome egg negative but positive for schisto-
some-specific IgG and IgE [63]).
First, this study confirms that ILC2s can be identified in human peripheral blood using Lin-
CD45+CD127+ cells in combination with CD161+ and CD294+ in a population of young
African children.
This study, shows for the first time that proportions of human blood ILC2s are diminished
during an infection with trematodes. The strongest effect was observed in the youngest age
group. Reductions in proportions of ILC2s could theoretically arise in two ways; due to a re-
duction in generation/maintenance of the cells in people infected with S. haematobium para-
sites. Alternatively, ILC2s could migrate and accumulate at the site of infection or to the tissues
where eggs get trapped, initiating a localised immune response thereby leading to a reduction
of the cells in peripheral blood. Furthermore reduced levels of CD127 could indicate a reduced
responsiveness to IL-7 and thereby ILC2 survival. However, expression levels did not show any
variation which supports reduced responsiveness to IL-7. In this present study ILC2s are quan-
tified as proportions. Changes in ILC2 proportions due to an increase of other cell types within
Lin-CD45+ cells cannot be excluded. However, our results are consistent with those from a
previous study on blood ILC2s, indicating that in a TH2 mediated disease, ILC2s are lower in
patients compared to controls [35]. In contrast a recent study showed in 21 people with diverse
filarial infections (Loa loa,Wuchereria bancrofti and with Onchocerca volvulus) an increase of
ILCs characterised by CD127+CD117+ [7]. However infected people were aged 25–66 years
and therefore significantly older than even in the oldest age group investigated in this study, in
which ILC2s were also slightly higher in egg positive compared to egg negative people, which
may become significant if older people analysed.
Interestingly, reduced ILC2s were mainly observed in the youngest children, whereas in
older children (14–18 years) there were no differences between egg negative and positive indi-
viduals. These differences are likely to be related to the dynamics of infection and the immune
response due to ILC2s may have different dynamics compared to the development of protective
acquired immunity. Age-related changes of cellular, antibody and cytokine pattern in the con-
text of schistosome infection have been reported previously [24, 64, 65] and such pattern are
supported by theoretical models of helminth infections [66]. These changes have been taken to
represent population changes from susceptibility to infection the development of protective ac-
quired immunity [66]. Parasitological and immuno-epidemiological studies show that the egg
negative children in the youngest age group in this population have yet to acquire infection (no
parasite specific—IgM responses which are indicative of exposure to parasite life stages). The
remaining study population are either currently infected (indicated by the presence of parasite
eggs) or have had previous infection and are now putatively immune (indicated by the absence
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of parasite eggs in combination with the presence of parasite-specific immune responses asso-
ciated with resistance to infection such as anti-worm antibodies (IgE, IgG1, IgE/IgG4 ratio)
and parasite specific cellular responses (IL-5) as previously reported [25, 58, 67]). Thus, in this
population, the youngest egg negative children are the only ones who have not yet experienced
a schistosome infection, and the observed changes in ILC2s in this age group upon infection,
suggests that these cells are important in the early phase of the immune response, when the
TH2 pathway is initially triggered, rather than in the later phases of infection, when TH2 re-
sponses become established. This is consistent with our results from studies of the myeloid
dendritic cells in this population [24], which show a similar pattern. Indeed it has been shown
that ILC2s, in particular, provide an early source of IL-13 during experimental helminth infec-
tion [4]. Dynamic changes in the immune response to schistosomes are well documented and
age-related changes of cellular immune responses have been previously reported in this and
other study populations [16, 24, 25].
Clearance of S. haematobium infection following curative treatment with the anti-helmin-
thic drug praziquantel caused an increase in ILC2 proportions, recovering to levels comparable
to egg negative 14–18 year old participants, who have already developed natural protective im-
munity against parasites [25]. This is in keeping with earlier studies showing that chemothera-
py accelerates the development of protective acquired immunity against schistosomes [59] as
well as studies from this population showing that chemotherapy induced cellular responses as-
sociated with resistance against re-infection [50]. However due to the small sample size post-
treatment, this result requires further verification.
Both IL-33 and TSLP are important in ILC2 activation and propagation. There was no sig-
nificant association with systemic levels of IL-33 or TSLP with schistosome infection prior to
treatment. Hence systemic levels of these cytokines do not explain the alterations in blood
ILC2s and do not indicate a different activation status. However, if changes in ILC2 proportion
are due to migration, IL-33 and TSLP might still play a role if regulated locally (in which case
local levels of the cytokines would not necessarily be reflected systemically). We have obtained
supportive evidence for the importance IL-33 by analysing the effect of a specific IL-33 single
nucleotide polymorphisms (SNP) showing that allele variation influences schistosome infec-
tion intensity without influencing systemic IL-33 levels (manuscript in preparation).
In addition, systemic TH2 cytokines IL-4, IL-5 and IL-13 did not show significant associa-
tions with peripheral ILC2s. However, if changes in ILC2s are due to migration, ILC2 activa-
tion could be still initiated locally and play an important role in the immune response. This is
supported by the finding that systemic TH2 cytokines are only associated to infection in the
oldest age group, indicating that a classical TH2 response is more important and reflected on
systemic levels in older chronically infected individuals. Further studies are required to analyse
the activation status of ILC2s in infected people relative to their expression levels of GATA-3,
IL-5 and IL-13 as well as receptors for IL-33 and TSLP. Recently is has been reported that in
mouse models IL-9 and amphiregulin are important in the function of ILC2s [68, 69]. Howev-
er, data in humans are sparce and both IL-9 and amphiregulin were not incorporated when
this study was carried out.
Increased levels of TSLP were observed 6 weeks after treatment, which suggests that TSLP
may be involved in the increase of ILC2s following treatment, but no change in IL-33 was ob-
served after treatment. This latter result contradicts previous reports of an increase in IL-33
several weeks after treatment [33]. Further studies are required to clarify the role of IL-33 in
human infections with S. haematobium and should also include IL-25, which was not analysed
during this study due to limitations in blood levels that could be collected safely from the
younger children.
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In summary, this is the first study to report peripheral blood ILC2s being diminished in
young children suggesting that ILC2s may play a role in the immune responses to human hel-
minth infection before the establishment of schistosome protective immunity. Clearly further
mechanistic studies are required to determine how ILC2 levels are diminished in helminth in-
fection and how they are restored following removal of the helminth infection by curative treat-
ment. Nonetheless, this study validates the paradigms demonstrated in experimental studies of
an association between parasitic infection and ILC2 cells.
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